Sygnis SA (WSE:SYG)
Poland · Delayed Price · Currency is PLN 2.600
+0.020 (0.78%)
At close: Oct 10, 2025
Sygnis Market Cap
Sygnis has a market cap or net worth of 66.93 million as of October 10, 2025. Its market cap has increased by 266.23% in one year.
Market Cap
66.93M
Enterprise Value
72.65M
Revenue
15.41M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.60
Market Cap Chart
Since March 16, 2012, Sygnis's market cap has increased from 6.21M to 66.93M, an increase of 978.00%. That is a compound annual growth rate of 19.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 66.93M | 579.87% |
| Dec 30, 2024 | 9.84M | -56.47% |
| Dec 29, 2023 | 22.62M | -56.95% |
| Dec 30, 2022 | 52.54M | 10.53% |
| Dec 30, 2021 | 47.53M | 177.19% |
| Dec 30, 2020 | 17.15M | 568.20% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 6.11B |
| NEUCA | 3.24B |
| Synektik Spólka Akcyjna | 2.19B |
| Voxel | 1.82B |
| Celon Pharma | 1.22B |
| Selvita | 675.48M |
| Centrum Medyczne ENEL-MED | 523.19M |
| Ryvu Therapeutics | 506.61M |